Gastroenterology
RSSArticles
-
Clinical Briefs By Louis Kuritzky, MD
Based upon a presumed direct relationship with LDL lowering and reduction in CV events for persons with vasculopathy, many clinicians enthusiastically embraced the combination of ezetimibe with statins, especially when therapeutic LDL goals were difficult to attain with a statin alone. -
Capsaicin Patch 8% (Qutenza™)
The FDA has approved capsaicin in a high-concentration, matrix-formulated dermal patch. It is designed to deliver a therapeutic dose into the skin during a 60-minute application. Capsaicin patch is marketed by NeurogesX, Inc., as Qutenza™ -
Lemierre's Syndrome and Pharyngitis
Fusobacterium necrophorum causes pharyngitis just as often as group A beta-hemolytic streptococcus in adolescents and young adults, and can result in the life-threatening Lemierre's syndrome. Macrolides should be avoided when this pathogen is suspected. -
Clinical Briefs
-
Prognosis of First-Degree AV Block
-
ECG Review
-
A New, Effective Treatment for Obstructive Sleep Apnea: Hypoglossal Nerve Stimulation
-
Red+Blue for Heart Protection
-
When Two is Better Than One
-
Clinical Briefs